Improving dog vaccinations to prevent rabies in Africa
Improving dog vaccinations: a development and feasibility study to pave the way for effective, synchronized dog vaccination campaigns in Africa
This study is looking to improve dog vaccination efforts in Africa to help prevent rabies, which sadly causes many deaths each year, by trying out new ways to get dog owners involved in vaccination campaigns, just like successful programs in Latin America.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ifakara Health Institute NIH-funded |
| Lab location | 1 site (Dar-Es-Salaam, Tanzania U Rep) |
| Project ID | NIH-10983847 on NIH RePORTER |
What this research studies
This research aims to enhance dog vaccination efforts in Africa to combat rabies, a disease that causes approximately 59,000 human deaths annually. The study will explore synchronized vaccination campaigns, inspired by successful models in Latin America, to improve participation among dog owners. By combining media outreach with coordinated vaccination efforts, the research seeks to achieve the critical 70% vaccination coverage needed to effectively prevent rabies transmission to humans. The implementation trial will assess the feasibility and effectiveness of this approach across various communities.
Who could benefit from this research
Good fit: Ideal candidates for this research include dog owners in Africa, particularly in regions with high rabies incidence.
Not a fit: Patients who do not own dogs or live in areas with low rabies risk may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the incidence of rabies in both dogs and humans, ultimately saving lives.
How similar studies have performed: Previous research in Latin America has shown that synchronized vaccination campaigns can effectively increase vaccination coverage and reduce rabies incidence.
Where this research is happening
Dar-Es-Salaam, Tanzania U Rep
- Ifakara Health Institute — Dar-Es-Salaam, Tanzania U Rep (Active)
Researchers
- Principal investigator: Maganga, Sambo — Ifakara Health Institute
- Study coordinator: Maganga, Sambo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.